Aligos Therapeutics, Inc. ALGS Q2 2026 earnings

FAQ

When did Aligos Therapeutics, Inc. report Q2 2026 earnings?

Aligos Therapeutics, Inc. (ALGS) reported Q2 2026 earnings on August 6, 2026 before market open.

What were Aligos Therapeutics, Inc.'s Q2 2026 revenue and EPS?

Aligos Therapeutics, Inc. reported revenue of $27.8M and eps of $-0.14 for Q2 2026.

Did Aligos Therapeutics, Inc. beat estimates in Q2 2026?

Revenue beat the consensus estimate of $24.7M by $3.1M. EPS beat the consensus estimate of $-1.09 by $0.95.

How did Aligos Therapeutics, Inc.'s Q2 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 2778.5% from $965.0K a year earlier and eps grew 90.8% from $-1.53.

Where can I find Aligos Therapeutics, Inc.'s Q2 2026 SEC filings?

You can read the 8-K earnings release (0001171843-26-005294) and the 10-Q periodic report (0001193125-26-336851) directly on SEC EDGAR. The filing index links above go to sec.gov.